drugset / Trial / NCT00424827
A Trial of Chemo & Radiation Therapy for Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, non-randomized, combination study of cetuximab, gemcitabine, 5-FU, and external beam radiotherapy in patients with locally advanced, non-metastatic pancreatic cancer.
Timeline
- Start
- 2006-06
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 200 mg/m2 | — |